Back to search

Article

Genomic analysis of response to neoadjuvant chemotherapy in esophageal adenocarcinoma

2021-03-28

Abstract excerpt

Neoadjuvant therapy followed by surgery is the standard of care for locally advanced esophageal adenocarcinoma (EAC). Unfortunately, response to neoadjuvant chemotherapy (NAC) is poor (<20%), as is the overall survival benefit at 5 years (5%). The EAC genome is complex and heterogeneous between patients, and it is not yet understood whether specific mutational patterns may result in chemotherapy sensitivity or res...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
b590c8b9-d4f3-54fd-bd41-2919081d9536
DOI
10.1101/2021.03.26.437144
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Genomic analysis of response to neoadjuvant chemotherapy in esophageal adenocarcinomaDOI 10.1101/2021.03.26.437144
Select a neighboring publication to make it the new centre.